Trial
NCT03201939
Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Vanderbilt University Medical Center
Collaborators
Aminu Kano Teaching Hospital; SAIC-Frederick, Inc.; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
HIV/AIDS
Intervention
Lisinopril
Why stopped
DSMB recommendations, laboratory quality control (QC) issues. All lab Q/C issues addressed; DSMB approved study re-opening, but due to length of time required to address lab QC issues, insufficient follow-up time was available to complete study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-26